Antimicrobial agents and chemotherapy

• 

  Año 2005, Vol. 49, Número 12

  • DX-619, a Novel Des-Fluoro(6) Quinolone Manifesting Low Frequency of Selection of Resistant Staphylococcus aureus Mutants: Quinolone Resistance beyond Modification of Type II Topoisomerases

    Q. C. Truong Bolduc, J. Strahilevitz

    págs. 5051-5057

    

  • Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity

    A. Louie, M. Deziel

    págs. 5058-5068

    

  • Erythromycin Resistance and Genetic Elements Carrying Macrolide Efflux Genes in Streptococcus agalactiae

    J. M. Marimon

    págs. 5069-5074

    

  • beta-Lactam Resistance in Staphylococcus aureus Cells That Do Not Require a Cell Wall for Integrity

    E. Fuller, F. Nattress, C. Elmer

    págs. 5075-5080

    

  • Pharmacodynamic Model To Describe the Concentration-Dependent Selection of Cefotaxime-Resistant Escherichia coli

    S. K. Olofsson

    págs. 5081-5091

    

  • Population Pharmacokinetics of Amphotericin B Lipid Complex in Neonates

    G. Wurthwein, A. H. Groll

    págs. 5092-5098

    

  • Effective Antimicrobial Regimens for Use in Humans for Therapy of Bacillus anthracis Infections and Postexposure Prophylaxis

    M. R. Deziel

    págs. 5099-5106

    

  • In Vivo Measurement of Levofloxacin Penetration into Lung Tissue after Cardiac Surgery

    K. Skhirtladze, D. Hutschala

    págs. 5107-5111

    

  • Analysis of the Contribution of Individual Substituents in 4,6-Aminoglycoside-Ribosome Interaction

    S. N. Hobbie

    págs. 5112-5118

    

  • Moxifloxacin and Azithromycin but not Amoxicillin Protect Human Respiratory Epithelial Cells against Streptococcus pneumoniae In Vitro when Administered up to 6 Hours after Challenge

    C. Albers, M. Ulrich, J. G. Moller

    págs. 5119-5122

    

  • Antichagasic Activity of Komaroviquinone Is Due to Generation of Reactive Oxygen Species Catalyzed by Trypanosoma cruzi Old Yellow Enzyme

    B. K. Kubata, Z. Kabututu, N. Uchiyama, J. Nakajima-Shimada

    págs. 5123-5126

    

  • Pitfalls in Estimating Piperaquine Elimination

    N. Lindegardh, J. Tarning

    págs. 5127-5128

    

  • Type V Staphylococcal Cassette Chromosome mec in Community Staphylococci from Australia

    F. G. O Brien, J. C. Pearson, K. J. Christiansen, G. W. Coombs

    págs. 5129-5132

    

  • Efficacy of Caspofungin against Aspergillus terreus

    A. W. Fothergill, E. Spreghini, F. Barchiesi, A. Santinelli

    págs. 5133-5135

    

  • In Vitro Activity of Ravuconazole against 923 Clinical Isolates of Nondermatophyte Filamentous Fungi

    Manuel Cuenca Estrella

    págs. 5136-5138

    

  • Caspofungin and Liposomal Amphotericin B Therapy of Experimental Murine Scedosporiosis

    J. R. Graybill, S. Hernandez, D. I. McCarthy, L. K. Najvar, R. Bocanegra

    págs. 5139-5141

    

  • Horizontal Transfer of Erythromycin Resistance from Clostridium difficile to Butyrivibrio fibrisolvens

    F. Barbanti, P. Spigaglia, P. Mastrantonio

    págs. 5142-5145

    

  • Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways

    D. P. Kontoyiannis, N. P. Wiederhold

    págs. 5146-5148

    

  • Variants of the Klebsiella pneumoniae OKP Chromosomal Beta-Lactamase Are Divided into Two Main Groups, OKP-A and OKP-B

    V. Passet, P. A. D. Grimont, F.X. Weill, C. Fevre

    págs. 5149-5152

    

  • VIM-12, a Novel Plasmid-Mediated Metallo-beta-Lactamase from Klebsiella pneumoniae That Resembles a VIM-1/VIM-2 Hybrid

    S. Pournaras, L. S. Tzouvelekis, A. Ikonomidis

    págs. 5153-5156

    

  • Effect of Voriconazole Combined with Micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani

    K. Heyn, S. Salvenmoser, A. Tredup, F.-M. C. Muller

    págs. 5157-5159

    

  • A Cysteine Protease Inhibitor Protects Dogs from Cardiac Damage during Infection by Trypanosoma cruzi

    S. C. Barr, B. G. Kornreic, K. L. Warner

    págs. 5160-5161

    

  • Assessing the In Vitro Effectiveness of Antimicrobials against Mycoplasma mycoides subsp. mycoides Small-Colony Type To Reduce Contagious Bovine Pleuropneumonia Infection

    S. Bisgaard Frantzen, R. D. Ayling

    págs. 5162-5165

    

  • In Vitro Synergy of Daptomycin plus Rifampin against Enterococcus faecium Resistant to both Linezolid and Vancomycin

    D. Ashcraft, G. Pankey

    págs. 5166-5168

    

  • Interaction of Monobenzamidine-Linked Trypanocides with the Trypanosoma brucei P2 Aminopurine Transporter

    M. L. Stewart

    págs. 5169-5171

    

  • Cloning and Functional Analysis of the Gene Encoding the 33- to 36-Kilodalton Outer Membrane Protein Associated with Carbapenem Resistance in Acinetobacter baumannii

    M. del Mar Tomas

    págs. 5172-5175

    

  • High Rate of Resistance to Quinupristin-Dalfopristin in Enterococcus faecium Clinical Isolates from Korea

    K. S. Ko, W. S. Oh, J.H. Song

    págs. 5176-5178

    

  • Novel Rearrangement of a Class 2 Integron in Two Non-Epidemiologically Related Isolates of Acinetobacter baumannii

    M. S. Ramirez

    págs. 5179-5181

    

  • Antipneumococcal Activity of Dalbavancin Compared to Other Agents

    L. M. Ednie, G. Lin, K. Smith, P. C. Appelbaum

    págs. 5182-5184

    

  • Human Immunodeficiency Virus Type 1 Latency Model for High-Throughput Screening

    S. Micheva Viteva

    págs. 5185-5188